04/06/2026
Weight loss drugs are everywhere right now. But do they actually work — and what happens when you stop taking them?
In this week’s Supplement Sunday, we break down GLP-1 receptor agonists like Ozempic, Wegovy, and Zepbound — what they do to your brain, stomach, and pancreas, the clinical trial data behind them, and the risks most people overlook.
Here’s what the evidence shows:
Tirzepatide (Zepbound/Mounjaro) produced ~20-22% bodyweight reduction in clinical trials.
Semaglutide (Ozempic/Wegovy) lands around 14-16%.
These drugs do NOT permanently alter your metabolism.
Studies suggest ~60% of lost weight may return within a year of stopping treatment.
Beyond fat loss, they also improve cardiovascular risk, blood sugar stability, and insulin resistance.
The verdict: effective medical tools — not permanent cures. Sustainable results still require the foundation of proper training and nutrition.
Save this for anyone asking about weight loss drugs. Drop a comment with what supplement you want us to cover next, or DM us for coaching.